Why the study?
Giant cell myocarditis is a rare, severe disease where recurrence after heart transplantation remains high and long-term survival without transplantation is limited, prompting exploration of strategies to improve prognosis.
Population
Five biopsy-confirmed GCM patients at Samsung Medical Center
Design
Retrospective case series
Authors
Loading...
May inform rare GCM management strategies; hypothesis-generating and requires larger prospective validation before practice change.
This case series highlights that early histologic diagnosis, prompt immunosuppressive therapy, and mechanical circulatory support are critical for improving survival in fulminant giant cell myocarditis.
Hong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: